Yuanyuan Jin
Co-Founder & COO,
Bound Therapeutics
United States
Dr. Yuanyuan Jin is a visionary biotechnology entrepreneur with deep expertise in molecular pharmacology and structural biology. As the Co-founder and Chief Operating Officer of Bound Therapeutics, she has played a transformative role in developing and commercializing an innovative RNA therapeutics platform to combat aggressive cancers.
Dr. Jin earned her PhD in Molecular Pharmacology and Structural Biology from Thomas Jefferson University, where she pioneered a groundbreaking platform to inhibit oncogenic microRNAs. Her career is built on a strong foundation in molecular biology, drug discovery, and bioinformatics. With over a decade of industry experience, she has successfully led the research and development of multiple lead molecules, gained deep expertise in tissue-specific RNA drug delivery, and leveraged AI/ML technologies for de novo peptide ligand design.
In addition to her scientific achievements, Dr. Jin is recognized for her leadership in forging strategic partnerships, negotiating licensing agreements, and securing government funding. Her commitment to innovation and excellence continues to drive the growth, impact, and success of Bound Therapeutics in advancing cutting-edge biotechnological solutions.
Suffix
PhD
Sessions
-
10-Feb-2025Bound Therapeutics
)
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}